Early-onset fetal growth restriction treated with the long-acting phosphodiesterase-5 inhibitor tadalafil: a case report
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1752-1947
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Early-onset fetal growth restriction treated with the long-acting phosphodiesterase-5 inhibitor tadalafil: a case report ; volume:10 ; number:1 ; day:8 ; month:11 ; year:2016 ; pages:1-5 ; date:12.2016
Journal of medical case reports ; 10, Heft 1 (8.11.2016), 1-5, 12.2016
- Creator
-
Sakamoto, Mito
- Contributor
-
Osato, Kazuhiro
Kubo, Michiko
Nii, Masafumi
Tanaka, Hiroaki
Murabayashi, Nao
Umekawa, Takashi
Kamimoto, Yuki
Ikeda, Tomoaki
SpringerLink (Online service)
- DOI
-
10.1186/s13256-016-1098-x
- URN
-
urn:nbn:de:1111-2016120116262
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sakamoto, Mito
- Osato, Kazuhiro
- Kubo, Michiko
- Nii, Masafumi
- Tanaka, Hiroaki
- Murabayashi, Nao
- Umekawa, Takashi
- Kamimoto, Yuki
- Ikeda, Tomoaki
- SpringerLink (Online service)
Other Objects (12)
Long-Acting Reversible Contraception
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Development of long-acting ARV’s
Creation of a long-acting nanoformulated dolutegravir
A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β2-Agonist (LABA) Combinations in COPD
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
Adolescents and Long-Acting Reversible Contraception: Lessons from Mexico
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Untersuchungen über die Entstehung von Long-acting thyroid stimulator (LATS)
Long‐Acting Microparticle Formulation of Griseofulvin for Ocular Neovascularization Therapy
Recent progress in advanced biomaterials for long-acting reversible contraception
A randomized controlled trial of long-acting muscarinic antagonist and long-acting β2 agonist fixed-dose combinations in patients with chronic obstructive pulmonary disease
Long-Acting Reversible Contraception
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Development of long-acting ARV’s
Creation of a long-acting nanoformulated dolutegravir
A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β2-Agonist (LABA) Combinations in COPD
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
Adolescents and Long-Acting Reversible Contraception: Lessons from Mexico
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Untersuchungen über die Entstehung von Long-acting thyroid stimulator (LATS)
Long‐Acting Microparticle Formulation of Griseofulvin for Ocular Neovascularization Therapy
Recent progress in advanced biomaterials for long-acting reversible contraception
A randomized controlled trial of long-acting muscarinic antagonist and long-acting β2 agonist fixed-dose combinations in patients with chronic obstructive pulmonary disease
Long-Acting Reversible Contraception
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Development of long-acting ARV’s
Creation of a long-acting nanoformulated dolutegravir
A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β2-Agonist (LABA) Combinations in COPD
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
Adolescents and Long-Acting Reversible Contraception: Lessons from Mexico
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Untersuchungen über die Entstehung von Long-acting thyroid stimulator (LATS)
Long‐Acting Microparticle Formulation of Griseofulvin for Ocular Neovascularization Therapy
Recent progress in advanced biomaterials for long-acting reversible contraception